PWMG
NVAX icon

Provence Wealth Management Group’s Novavax NVAX Stock Holding History

Provence Wealth Management Group’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$1.92K Hold
400
– – ﹤0.01% 396
2023
Q3 		$2.9K Buy
+400
New +$3.2K ﹤0.01% 390

Other funds holding NVAX

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Provence Wealth Management Group's NVAX Position: Q4 2023 in Review

Provence Wealth Management Group held its Novavax (NVAX) position steady in Q4 2023 at 400 shares worth $1.92K. The position accounts for ﹤0.01% of the portfolio, ranked #396.

Provence Wealth Management Group first reported a position in NVAX in Q3 2023 and has held it in 2 quarters since. The position peaked at $2.9K in Q3 2023. 200 funds tracked by Wall St. Rank hold NVAX as of Q4 2023.

  • Provence Wealth Management Group held 400 shares of Novavax worth $1.92K as of Q4 2023.
  • Provence Wealth Management Group left its Novavax share count unchanged in Q4 2023.
  • Novavax made up ﹤0.01% of Provence Wealth Management Group's portfolio in Q4 2023, its #396 holding.
  • Provence Wealth Management Group first reported a position in Novavax in Q3 2023 and has held it in 2 quarters since.
  • Provence Wealth Management Group's Novavax position peaked at $2.9K in Q3 2023.
  • 200 funds tracked by Wall St. Rank held Novavax as of Q4 2023.

Based on Provence Wealth Management Group's 13F filing for Q4 2023, filed 6 Feb 2024.